http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2670203-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82009d5c1f5b652ce02b4209bfd4d878 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-49 |
| filingDate | 2018-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e871ab64b88ae8093fd9a75fb876a444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74adaa3255f7801d12a1657ff0a46dd5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15745251bcc88126d316e0d1386c3797 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfd3560d9f462de929ee502c38276f58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cba3d23530bca5eb23631225eb16442b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5df9e2c9d91e640e154d995b92793d76 |
| publicationDate | 2018-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2670203-C1 |
| titleOfInvention | Method for treatment of ischemic stroke |
| abstract | FIELD: medicine.SUBSTANCE: invention relates to the field of medicine and is a method of treatment of ischemic stroke (AI), including thrombolytic therapy, characterized in that the drug is prescribed Fortelisinin a dose of 10 mg, which is administered with a single bolus for 10 seconds, regardless of body weight, no later than 4.5 hours from the onset of the disease in patients 18 years of age and older.EFFECT: invention provides for the acceleration and simplification of the administration of the preparation, which makes it possible to expand the possibility of using the method in a therapeutic window limited to 4½ hours; reduction in the fall of fibrinogen; decrease the mortality of AI and increase the percentage of good functional recovery of patients.1 cl, 1 tbl, 4 ex |
| priorityDate | 2018-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.